VEON vs CCOI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

VEON

36.5
AI Score
VS
CCOI Wins

CCOI

39.2
AI Score

Investment Advisor Scores

VEON

37score
Recommendation
AVOID NEW MONEY

CCOI

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric VEON CCOI Winner
Forward P/E 7.9239 5000 VEON
PEG Ratio 2.2274 85.8913 VEON
Revenue Growth 16.9% -4.2% VEON
Earnings Growth -78.9% 22809.2% CCOI
Tradestie Score 36.5/100 39.2/100 CCOI
Profit Margin 1.2% -5.1% VEON
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

VEON 1M: +14.4% · 3M: +60.6% CCOI 1M: -2.1% · 3M: -38.8%

Current Technical Phase

VEON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.4% over 20 days), RSI 66

RSI (14): 66.5 · Price: $83.01

CCOI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.5%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $7.48

Fundamentals Snapshot

Metric VEON CCOI
Market Cap — —
Forward P/E 10.0 -2.9
Trailing P/E 100.3 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.9% 0.5%
Operating Margin 0.3% -0.1%
EPS 0.79 -0.94
Dividend Yield — 0.14%

Frequently Asked Questions

Based on our detailed analysis, CCOI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.